Concurrent chemoradiotherapy for locoregionally advanced salivary gland malignancies
Head & Neck, 05/02/2012Rosenberg L et al.
Chemoradiotherapy (CRT) for salivary gland malignancies has acceptable toxicity, CRT is proven beneficial for many other cancers, and some salivary gland malignancies are clinically responsive to chemotherapy. CRT, therefore, should be considered for treatment of high–risk salivary gland malignancies.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.